ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 74 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,000 | -33.3% | 10,339 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $33,000 | -15.4% | 10,339 | -30.3% | 0.00% | 0.0% |
| Q4 2016 | $39,000 | -32.8% | 14,839 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $58,000 | +3.6% | 14,839 | -28.8% | 0.00% | -25.0% |
| Q2 2016 | $56,000 | -12.5% | 20,839 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $64,000 | -17.9% | 20,839 | -18.9% | 0.00% | 0.0% |
| Q3 2015 | $78,000 | -28.4% | 25,709 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $109,000 | +10.1% | 25,709 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $99,000 | -42.8% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $173,000 | +22.7% | 25,709 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $141,000 | -46.6% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $264,000 | -14.6% | 25,709 | 0.0% | 0.01% | -11.1% |
| Q1 2014 | $309,000 | -46.2% | 25,709 | -49.3% | 0.01% | -50.0% |
| Q4 2013 | $574,000 | +68.3% | 50,709 | 0.0% | 0.02% | +63.6% |
| Q3 2013 | $341,000 | -27.4% | 50,709 | 0.0% | 0.01% | -38.9% |
| Q2 2013 | $470,000 | – | 50,709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 1,652,190 | $3,817,000 | 2.58% |
| LINCOLN CAPITAL CORP | 62,000 | $143,000 | 0.13% |
| Laurion Capital Management LP | 1,944,727 | $4,492,000 | 0.08% |
| Cedar Wealth Management, LLC | 46,395 | $107,000 | 0.08% |
| Fosun International Ltd | 301,708 | $709,000 | 0.04% |
| BCWM, LLC | 35,100 | $811,000 | 0.04% |
| Engineers Gate Manager LP | 170,800 | $395,000 | 0.03% |
| Alpine Global Management, LLC | 45,211 | $104,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $578,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 73,778 | $170,000 | 0.02% |